These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 18283262

  • 1. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
    Ławnicka H, Pisarek H, Kunert-Radek J, Pawlikowski M.
    Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
    [Abstract] [Full Text] [Related]

  • 2. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M, Lawnicka H, Pisarek H, Kunert-Radek J, Radek M, Culler MD.
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [Abstract] [Full Text] [Related]

  • 3. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
    Zatelli MC, Piccin D, Vignali C, Tagliati F, Ambrosio MR, Bondanelli M, Cimino V, Bianchi A, Schmid HA, Scanarini M, Pontecorvi A, De Marinis L, Maira G, degli Uberti EC.
    Endocr Relat Cancer; 2007 Mar; 14(1):91-102. PubMed ID: 17395978
    [Abstract] [Full Text] [Related]

  • 4. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
    Padova H, Rubinfeld H, Hadani M, Cohen ZR, Nass D, Taylor JE, Culler MD, Shimon I.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):214-8. PubMed ID: 18276067
    [Abstract] [Full Text] [Related]

  • 5. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
    Gruszka A, Kunert-Radek J, Radek A, Pisarek H, Taylor J, Dong JZ, Culler MD, Pawlikowski M.
    Life Sci; 2006 Jan 11; 78(7):689-93. PubMed ID: 16115652
    [Abstract] [Full Text] [Related]

  • 6. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M.
    Neuro Endocrinol Lett; 2009 Mar 11; 30(1):107-10. PubMed ID: 19300395
    [Abstract] [Full Text] [Related]

  • 7. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
    Korsisaari N, Ross J, Wu X, Kowanetz M, Pal N, Hall L, Eastham-Anderson J, Forrest WF, Van Bruggen N, Peale FV, Ferrara N.
    Clin Cancer Res; 2008 Jan 01; 14(1):249-58. PubMed ID: 18172277
    [Abstract] [Full Text] [Related]

  • 8. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
    Deng J, Shi Y, Yin J.
    Chin Med J (Engl); 1997 Sep 01; 110(9):678-81. PubMed ID: 9642323
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
    Cap J, Marekova M, Cerman J, Malirova E, Suba P, Netuka D, Hana V, Marek J.
    Gen Physiol Biophys; 2003 Jun 01; 22(2):201-12. PubMed ID: 14661732
    [Abstract] [Full Text] [Related]

  • 10. Genetic abnormalities of somatostatin receptors in pituitary tumors.
    Lania A, Mantovani G, Spada A.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):180-6. PubMed ID: 17913341
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin and somatostatin receptors in Cushing's disease.
    Hofland LJ.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):199-205. PubMed ID: 18221833
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
    Danila DC, Haidar JN, Zhang X, Katznelson L, Culler MD, Klibanski A.
    J Clin Endocrinol Metab; 2001 Jul 14; 86(7):2976-81. PubMed ID: 11443154
    [Abstract] [Full Text] [Related]

  • 13. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
    Visser-Wisselaar HA, Van Uffelen CJ, Van Koetsveld PM, Lichtenauer-Kaligis EG, Waaijers AM, Uitterlinden P, Mooy DM, Lamberts SW, Hofland LJ.
    Endocrinology; 1997 Mar 14; 138(3):1180-9. PubMed ID: 9048625
    [Abstract] [Full Text] [Related]

  • 14. Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma.
    Arita K, Kurisu K, Tominaga A, Sugiyama K, Eguchi K, Hama S, Yoshioka H, Yamasaki F, Kanou Y.
    Hiroshima J Med Sci; 2004 Jun 14; 53(2):23-7. PubMed ID: 15453394
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland.
    Ueberberg B, Tourne H, Redmann A, Walz MK, Schmid KW, Mann K, Petersenn S.
    Horm Metab Res; 2005 Dec 14; 37(12):722-8. PubMed ID: 16372224
    [Abstract] [Full Text] [Related]

  • 16. Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells.
    Hofland LJ, Lamberts SW, Feelders RA.
    Neuroendocrinology; 2010 Dec 14; 92 Suppl 1():11-6. PubMed ID: 20829612
    [Abstract] [Full Text] [Related]

  • 17. In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists.
    Bocci G, Culler MD, Fioravanti A, Orlandi P, Fasciani A, Colucci R, Taylor JE, Sadat D, Danesi R, Del Tacca M.
    Eur J Clin Invest; 2007 Sep 14; 37(9):700-8. PubMed ID: 17696959
    [Abstract] [Full Text] [Related]

  • 18. Pituitary tumours: the sst/D2 receptors as molecular targets.
    Hofland LJ, Feelders RA, de Herder WW, Lamberts SW.
    Mol Cell Endocrinol; 2010 Sep 15; 326(1-2):89-98. PubMed ID: 20438803
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.
    Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U.
    Neuroendocrinology; 2001 Aug 15; 74(2):95-105. PubMed ID: 11474217
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms.
    Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW.
    Acta Neuropathol; 2006 Mar 15; 111(3):272-7. PubMed ID: 16538520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.